ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
Resolution of Anterior Uveal Infiltration of Acute Lymphoblastic Leukemia After CAR T-Cell Therapy
26 Nov 2024
On this episode of the JVRD Author's Forum podcast, Dr. Jose J. Echegaray, Retina Consultants of Orlando, discusses 'Resolution of Anterior Uveal Infiltration of Acute Lymphoblastic Leukemia After Chimeric Antigen Receptor T-Cell Therapy,' published in the November/December 2024 issue of JVRD. Host Dr. Timothy Murray and Dr. Echegaray discuss the key takeaways from this rare presentation of leukemia in the uveal tract, including the importance of early and accurate diagnosis through clinical and tissue-based assessments to guide treatment, and the potential of CAR T-cell therapy in treating systemic leukemia and uveal infiltration despite the risk for side effects, such as cytokine release syndrome, which must be carefully managed.For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2427 - Bret Weinstein
17 Dec 2025
The Joe Rogan Experience
#2426 - Cameron Hanes & Adam Greentree
16 Dec 2025
The Joe Rogan Experience
#487 – Irving Finkel: Deciphering Secrets of Ancient Civilizations & Flood Myths
12 Dec 2025
Lex Fridman Podcast
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money